IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Big Growth in CRAMS Contracts for Jubilant

1:46 PM MDT | July 24, 2007 | Chemical Week Editorial Staff

Jubilant Organosys (Noida), one of India’s largest drug discovery and pharma services companies, says it has signed several custom research and manufacturing services (CRAMS) contracts worth a combined $60 million. The value of the deals represents a 50% increase over deals signed last year. Jubilant says that almost $54 million worth of contracts are with European and U.S. firms, and include deals with unspecified life science multinationals. “We will continue to focus on investments in innovation and world-class manufacturing facilities,” says...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa